Comparison between Curis Lifesciences IPO and Flywings Simulator Training IPO.
Curis Lifesciences IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Flywings Simulator Training IPO is a SME Bookbuilding proposed to list at NSE SME.
| Curis Lifesciences IPO | Flywings Simulator Training IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Finaax Capital Advisors Private Limited | Gretex Corporate Services Ltd. Sobhagya Capital Options Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | RS Wealth Management Private Limited | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Curis Lifesciences IPO is up to ₹26.14 Cr whereas the issue size of the Flywings Simulator Training IPO is up to ₹54.19 Cr. The final issue price of Curis Lifesciences IPO is ₹128.00 per share and of Flywings Simulator Training IPO is ₹191.00 per share.
| Curis Lifesciences IPO | Flywings Simulator Training IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹120.00 per share | ₹181.00 per share |
| Issue Price (Upper) | ₹128.00 per share | ₹191.00 per share |
| Issue Price (Final) | ₹128.00 per share | ₹191.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 600 shares |
| Fresh Issue Size | 20,42,000 shares | 23,63,400 shares |
| Fresh Issue Size (Amount) | up to ₹26.14 Cr | up to ₹45.14 Cr |
| OFS Issue Size | 0 shares | 4,74,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹9.05 Cr |
| Issue Size Total | 20,42,000 shares | 28,37,400 shares |
| Issue Size Total (Amount) | up to ₹26.14 Cr | up to ₹54.19 Cr |
Curis Lifesciences IPO opens on Nov 07, 2025, while Flywings Simulator Training IPO opens on Dec 05, 2025. The closing date of Curis Lifesciences IPO and Flywings Simulator Training IPO is Nov 11, 2025, and Dec 09, 2025, respectively.
| Curis Lifesciences IPO | Flywings Simulator Training IPO | |
|---|---|---|
| Anchor Bid Date | Nov 06, 2025 | Dec 04, 2025 |
| Issue Open | Nov 07, 2025 | Dec 05, 2025 |
| Issue Close | Nov 11, 2025 | Dec 09, 2025 |
| Basis Of Allotment (Tentative) | Nov 12, 2025 | Dec 10, 2025 |
| Initiation of Refunds (Tentative) | Nov 13, 2025 | Dec 11, 2025 |
| Credit of Share (Tentative) | Nov 13, 2025 | Dec 11, 2025 |
| Listing date (Tentative) | Nov 14, 2025 | Dec 12, 2025 |
| Anchor Lockin End date 1 | Dec 11, 2025 | Jan 09, 2026 |
| Anchor Lockin End date 2 | Feb 09, 2026 | Mar 10, 2026 |
Curis Lifesciences IPO P/E ratio is 12.44, as compared to Flywings Simulator Training IPO P/E ratio of 13.41.
| Curis Lifesciences IPO | Flywings Simulator Training IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Curis Lifesciences Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 25% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.68 | 85.69 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.03 | 59.87 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.44 | 13.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹103.48 Cr. | ₹194.38 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 55.25 | 34.75 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 27.83 | 28.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.96 | 0.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.29 | ₹14.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 37.62 | 34.75 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Curis Lifesciences IPO Retail Individual Investors (RII) are offered 7,16,000 shares while in Flywings Simulator Training IPO retail investors are offered 7,16,000 shares. Qualified Institutional Buyers (QIB) are offered 4,08,000 shares in Curis Lifesciences IPO and 5,67,000 shares in Flywings Simulator Training IPO.
| Curis Lifesciences IPO | Flywings Simulator Training IPO | |
|---|---|---|
| Anchor Investor Reservation | 6,09,000 shares | 8,50,200 shares |
| Market Maker Reservation | 1,08,000 shares | 1,49,400 shares |
| QIB | 4,08,000 shares | 5,67,000 shares |
| NII | 3,09,000 shares | 4,26,600 shares |
| RII | 7,16,000 shares | 9,93,600 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 20,42,000 shares | 28,37,400 shares |
Curis Lifesciences IPO subscribed 74.39x in total, whereas Flywings Simulator Training IPO subscribed 1.67x.
| Curis Lifesciences IPO | Flywings Simulator Training IPO | |
|---|---|---|
| QIB (times) | 96.17x | 1.56x |
| NII (times) | 115.46x | 3.47x |
| Big NII (times) | 142.74x | 4.66x |
| Small NII (times) | 60.38x | 1.09x |
| RII (times) | 44.28x | 0.97x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 74.39x | 1.67x |
